Free Trial

Precision Optics (POCI) Competitors

Precision Optics logo
$4.37 +0.03 (+0.71%)
As of 09/12/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

POCI vs. LUCD, PROF, BSGM, PDEX, RCEL, OBIO, SPAI, NSPR, EDAP, and ZJYL

Should you be buying Precision Optics stock or one of its competitors? The main competitors of Precision Optics include Lucid Diagnostics (LUCD), Profound Medical (PROF), Biosig Technologies (BSGM), Pro-Dex (PDEX), Avita Medical (RCEL), Orchestra BioMed (OBIO), Safe Pro Group (SPAI), InspireMD (NSPR), EDAP TMS (EDAP), and Jin Medical International (ZJYL). These companies are all part of the "medical equipment" industry.

Precision Optics vs. Its Competitors

Lucid Diagnostics (NASDAQ:LUCD) and Precision Optics (NASDAQ:POCI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Lucid Diagnostics presently has a consensus price target of $3.65, indicating a potential upside of 254.37%. Given Lucid Diagnostics' stronger consensus rating and higher probable upside, research analysts clearly believe Lucid Diagnostics is more favorable than Precision Optics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Lucid Diagnostics
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Precision Optics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Lucid Diagnostics had 9 more articles in the media than Precision Optics. MarketBeat recorded 10 mentions for Lucid Diagnostics and 1 mentions for Precision Optics. Precision Optics' average media sentiment score of 1.91 beat Lucid Diagnostics' score of 0.60 indicating that Precision Optics is being referred to more favorably in the news media.

Company Overall Sentiment
Lucid Diagnostics Positive
Precision Optics Very Positive

74.0% of Lucid Diagnostics shares are owned by institutional investors. Comparatively, 13.7% of Precision Optics shares are owned by institutional investors. 6.8% of Lucid Diagnostics shares are owned by company insiders. Comparatively, 13.0% of Precision Optics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Lucid Diagnostics has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.38, meaning that its stock price is 62% less volatile than the S&P 500.

Precision Optics has higher revenue and earnings than Lucid Diagnostics. Precision Optics is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Lucid Diagnostics$4.35M25.69-$45.53M-$1.19-0.87
Precision Optics$17.63M1.92-$2.95M-$0.89-4.96

Precision Optics has a net margin of -32.84% compared to Lucid Diagnostics' net margin of -1,476.35%. Lucid Diagnostics' return on equity of 0.00% beat Precision Optics' return on equity.

Company Net Margins Return on Equity Return on Assets
Lucid Diagnostics-1,476.35% N/A -120.43%
Precision Optics -32.84%-54.03%-32.48%

Summary

Lucid Diagnostics beats Precision Optics on 9 of the 16 factors compared between the two stocks.

Get Precision Optics News Delivered to You Automatically

Sign up to receive the latest news and ratings for POCI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POCI vs. The Competition

MetricPrecision OpticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$33.77M$6.78B$5.78B$10.18B
Dividend YieldN/A1.20%5.73%4.60%
P/E Ratio-4.9626.0175.4626.02
Price / Sales1.92187.88466.1392.34
Price / CashN/A22.1825.8129.91
Price / Book2.665.0012.166.25
Net Income-$2.95M$176.38M$3.29B$270.76M
7 Day Performance-1.34%1.00%0.74%3.87%
1 Month Performance-6.77%2.09%5.00%5.49%
1 Year Performance-18.33%10.96%62.55%25.86%

Precision Optics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POCI
Precision Optics
0.8024 of 5 stars
$4.41
+1.6%
N/A-18.3%$33.77M$17.63M-4.9680Positive News
LUCD
Lucid Diagnostics
3.1673 of 5 stars
$1.27
+3.7%
$3.65
+187.4%
+21.7%$132.88M$4.35M-1.0770News Coverage
PROF
Profound Medical
2.2061 of 5 stars
$4.08
-0.7%
$11.00
+169.6%
-47.7%$123.52M$10.68M-2.79150Positive News
BSGM
Biosig Technologies
2.0407 of 5 stars
$4.11
+5.9%
$10.00
+143.3%
+1,316.9%$121.90M$40K0.0050Gap Down
PDEX
Pro-Dex
2.6866 of 5 stars
$36.39
+2.3%
$56.00
+53.9%
+23.9%$116.03M$66.59M13.48140News Coverage
RCEL
Avita Medical
2.4563 of 5 stars
$4.19
-0.5%
$11.60
+176.8%
-55.6%$112.07M$64.25M-2.13130
OBIO
Orchestra BioMed
3.064 of 5 stars
$2.71
-0.7%
$13.50
+398.2%
-55.8%$105.50M$2.64M-1.484Short Interest ↑
SPAI
Safe Pro Group
3.3399 of 5 stars
$7.49
+16.3%
$10.50
+40.2%
+163.2%$104.12M$2.17M-9.3611Trending News
Analyst Forecast
Analyst Revision
NSPR
InspireMD
3.6388 of 5 stars
$2.46
+2.5%
$4.50
+82.9%
-12.5%$102.63M$7.07M-3.2850News Coverage
Positive News
Short Interest ↓
EDAP
EDAP TMS
2.2174 of 5 stars
$2.80
+2.2%
$8.50
+203.6%
-24.4%$102.45M$69.18M-4.59230Short Interest ↑
ZJYL
Jin Medical International
N/A$0.65
+3.6%
N/A-75.9%$98.66M$23.50M0.00245Short Interest ↑

Related Companies and Tools


This page (NASDAQ:POCI) was last updated on 9/14/2025 by MarketBeat.com Staff
From Our Partners